Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases (Q28744267)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 13 December 2010)

Language	Label	Description	Also known as
English	Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases	scientific article (publication date: 13 December 2010)

Statements

scholarly article

0 references

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases (English)

0 references

0 references

human subject research project

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrea Rubbert-Roth

4

object named as

Andrea Rubbert-Roth

0 references

author name string

Olaf Schultz

1

0 references

Frank Oberhauser

2

0 references

Jasemine Saech

3

0 references

Andrea Rubbert-Roth

4

0 references

Moritz Hahn

5

0 references

Wilhelm Krone

6

0 references

Matthias Laudes

7

0 references

language of work or name

0 references

publication date

13 December 2010

0 references

0 references

5

0 references

e14328

0 references

12

0 references

copyright license

Creative Commons Attribution 4.0 International

13 December 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

16 March 2017

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

16 March 2017

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

16 March 2017

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

7 April 2017

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

7 April 2017

Certolizumab pegol: a new biologic targeting rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Anakinra for rheumatoid arthritis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Role of interleukin-6 signalling in glucose and lipid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Adalimumab for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Interleukin-6 in aging and chronic disease: a magnificent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

IL-6 signal transduction and its physiological roles: the signal orchestration model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

27 November 2018

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

How often has Lp(a) evolved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001451

3 June 2018

Relationship between adipocyte size and adipokine expression and secretion.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Discrepancy of interleukin-6 levels between end-stage renal disease patients and patients with acute-phase response with increased lipoprotein(a) concentrations

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014328

21 January 2018

Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma leptin levels and body fat distribution

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular disease in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/21179199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0014328

0 references

2010PLoSO...514328S

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28744267&oldid=1869788380"